XML 34 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings per Share (Tables)
 6 Months Ended
Aug. 04, 2018
Earnings Per Share [Abstract]  
Computation of basic and diluted earnings per share
The following tables show the computation of basic and diluted loss per common share for each period presented (in thousands, except per share amounts):
 
Three Months Ended
 
Six Months Ended
 
August 4, 2018
 
July 29, 2017
 
August 4, 2018
 
July 29, 2017
Basic:
 
 
 
 
 
 
 
Net loss
$
(16,922
)
 
$
(6,258
)
 
$
(48,600
)
 
$
(25,245
)
Distributed earnings allocated to participating securities
(68
)
 
(51
)
 
(131
)
 
(202
)
Net loss allocated to common shares
(16,990
)
 
(6,309
)
 
(48,731
)

(25,447
)
 
 
 
 
 
 
 
 
Basic weighted average shares outstanding
28,152

 
27,535

 
27,959

 
27,401

Basic loss per share
$
(0.60
)
 
$
(0.23
)
 
$
(1.74
)
 
$
(0.93
)
 
 
 
 
 
 
 
 
 
Three Months Ended
 
Six Months Ended
 
August 4, 2018
 
July 29, 2017
 
August 4, 2018
 
July 29, 2017
Diluted:
 

 
 

 
 
 
 
Net loss
$
(16,922
)
 
$
(6,258
)
 
$
(48,600
)
 
$
(25,245
)
Distributed earnings allocated to participating securities
(68
)
 
(51
)
 
(131
)
 
(202
)
Net loss allocated to common shares
(16,990
)
 
(6,309
)
 
(48,731
)

(25,447
)
 
 
 
 
 
 
 
 
Basic weighted average shares outstanding
28,152

 
27,535

 
27,959

 
27,401

Dilutive effect of stock awards
—

 
—

 
—

 
—

Diluted weighted average shares outstanding
28,152

 
27,535

 
27,959


27,401

Diluted loss per share
$
(0.60
)
 
$
(0.23
)
 
$
(1.74
)
 
$
(0.93
)
Number of anti-dilutive securities excluded from computation of diluted loss per share
The number of shares attributable to outstanding stock-based compensation awards that would have been considered dilutive securities, but were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive were as follows (in thousands):
 
Three Months Ended
 
Six Months Ended
 
August 4, 2018
 
July 29, 2017
 
August 4, 2018
 
July 29, 2017
Number of anti-dilutive shares due to net loss for the period
357

 
—

 
248

 
—

Number of anti-dilutive SARs due to exercise price greater than average market price of our common stock
—


119

 
29

 
138